Third Eye Scientific Solutions Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 19-12-2024
- Paid Up Capital ₹ 0.16 M
as on 19-12-2024
- Company Age 8 Year, 4 Months
- Last Filing with ROC 31 Mar 2021
- Revenue %
(FY 2019)
- Profit -107.65%
(FY 2019)
- Ebitda -125.58%
(FY 2019)
- Net Worth -254.78%
(FY 2019)
- Total Assets 28.33%
(FY 2019)
About Third Eye Scientific Solutions
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.16 M, as per Ministry of Corporate Affairs (MCA) records.
Krishnamachari Jaganathan, Ganesan Sarma, Qureshi Gulam, and One other member serve as directors at the Company.
- CIN/LLPIN
U73100KA2016PTC096357
- Company No.
096357
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Sep 2016
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Third Eye Scientific Solutions?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ganesan Sarma  | Director | 08-Sep-2016 | Current |
| Krishnamachari Jaganathan | Director | 08-Sep-2016 | Current |
| Qureshi Gulam | Director | 08-Sep-2016 | Current |
| Ramya Shanmuganathan | Director | 08-Sep-2016 | Current |
Financial Performance of Third Eye Scientific Solutions.
Third Eye Scientific Solutions Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 107.65% decrease in profit. The company's net worth observed a substantial decline by a decrease of 254.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Third Eye Scientific Solutions?
Unlock access to Third Eye Scientific Solutions's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Richplus Bio Fertilizers & Feeds Private LimitedActive 1 year 3 monthsGanesan Sarma is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Third Eye Scientific Solutions?
Unlock and access historical data on people associated with Third Eye Scientific Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Third Eye Scientific Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Third Eye Scientific Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
